Fig. 1

Study design. (A) The flowchart of patients enrolled in this study. T1DM, type 1 diabetes mellitus; DM, diabetes mellitus; T-T2DM, Tibetan type 2 diabetes mellitus; T-HC, Tibetan healthy controls. (B) Overview of workflow in this study. LC-MS, liquid chromatography-mass spectrometry